FTD can affect people earlier than other forms of dementia. (fizkes/Shutterstock)
Women especially might benefit from this surprising new screening tool that measures something you’ve probably never heard of
In a nutshell
- A simple 5-minute test called “phase angle” can predict memory problems, especially in women, by measuring muscle cell health
- Women with higher phase angles had 72% lower odds of cognitive impairment, suggesting muscle quality affects brain health more than previously thought
- The test uses equipment already available in most clinics and costs virtually nothing, making it a practical screening tool for early detection
KYOTO, Japan — Forget expensive brain scans or complex cognitive tests. Japanese researchers have discovered that a quick, painless measurement taken during a routine health checkup could help identify people at risk for memory problems and muscle loss — two conditions that often go hand in hand as we age.
The breakthrough centers around something called “phase angle,” a measurement obtained using a device similar to a fancy bathroom scale. Doctors can measure phase angle in about five minutes by having patients stand on metal plates while holding metal handles. This bioelectrical impedance analysis sends a tiny, unnoticeable electrical current through the body to assess the health of muscle cells.
Phase angle appears especially predictive for women. In a study of 263 middle-aged Japanese adults, women with higher phase angles were significantly less likely to have mild cognitive impairment — the stage that often precedes dementia. For every one-degree increase in phase angle, women’s odds of cognitive problems dropped by 72%.
How Muscle Quality Affects Brain Health
Phase angle essentially measures the quality and health of muscle cells by assessing how well cell membranes function and how much fluid is stored inside versus outside cells. It’s like a report card for your muscles’ internal health, separate from simply measuring how much muscle mass you have or how strong you are.
Previous research has shown that sarcopenia, the age-related loss of muscle mass and function, is closely linked to cognitive decline and dementia risk. But this new study reveals that muscle quality, not just quantity, might be even more important for brain health.
“PhA is an indicator of cellular health that reflects intracellular and extracellular fluid status, cellular nutritional status, cell membrane integrity and cell function,” the researchers write in their paper, published in the Journal of Cachexia Sarcopenia and Muscle.
Study participants, ranging from 40 to over 65 years old, underwent comprehensive testing including the Montreal Cognitive Assessment, a widely used screening tool for detecting mild cognitive impairment. About 31% of participants showed signs of cognitive problems that could indicate early memory loss.

Why Women May Be More Affected
While phase angle showed some correlation with memory function in men, the relationship was much stronger and more consistent in women. Women with higher phase angles not only had better overall cognitive scores but also performed better on specific brain functions including memory, language, executive function, and attention.
Men showed a positive correlation only with memory tasks, indicating that the muscle-brain connection might work differently between genders. This could be related to hormonal changes, particularly the decline in estrogen that occurs during menopause, which affects both muscle health and brain function.
Rather than trying to determine whether someone’s forgetfulness is normal aging or something more concerning, doctors could use phase angle as an objective biological marker that indicates risk before symptoms become obvious.
Phase Angle A Game-Changer For Early Detection?
This discovery is especially promising because of how easy and affordable the test is to perform. Bioelectrical impedance devices are already common in hospitals, clinics, and even some gyms. Unlike MRI brain scans that cost thousands of dollars, phase angle measurements cost virtually nothing once the equipment is available.
The test is also remarkably user-friendly. Patients don’t need to follow complex instructions or demonstrate physical skills that might be compromised in people with early cognitive problems—a significant advantage over traditional muscle strength tests like grip strength.
Several important caveats limit how broadly these findings can be applied right now. The study included only Japanese adults, and genetic and lifestyle factors could mean the results don’t translate directly to other populations. Additionally, this was a snapshot study rather than following people over time, so researchers can’t definitively say that low phase angle causes cognitive problems — only that they’re associated.
The sample size was also relatively modest, with just 100 women in the analysis. Study participants were also relatively healthy adults who sought routine health screenings, potentially missing people at highest risk for both muscle and cognitive problems.
Despite these limitations, the findings offer hope for developing better, more accessible screening tools for cognitive decline. Early detection of dementia risk could allow for lifestyle interventions like exercise, nutrition improvements, and social engagement, which might help preserve both muscle and brain health.
Scientists are increasingly studying “myokines,” which are proteins released by muscles during exercise that appear to benefit brain function, and might explain why physical fitness is so closely linked to cognitive health.
“Adopting personal behaviors aimed at improving muscle quality may serve as a preventative measure against dementia, especially in women,” notes lead author Dr. Kentaro Ikeue in a statement. “Thus, our study contributes to the development of innovative strategies to prevent both sarcopenia and dementia within the general population.”
For now, routine health checkups could potentially include phase angle measurements, especially for women over 40. While more research is needed before this becomes standard practice, the simplicity and low cost of the test make it an attractive option for widespread screening.
This five-minute measurement could eventually become as routine as checking blood pressure or cholesterol—a simple but powerful tool for catching cognitive decline before it progresses too far. In a world where dementia affects millions and effective treatments remain elusive, early detection tools like phase angle offer hope for prevention and intervention.
Paper Summary
Methodology
Researchers conducted a cross-sectional study of 263 Japanese adults aged 40 and older who underwent routine health examinations between August and November 2022. Participants had their body composition measured using bioelectrical impedance analysis, which calculates phase angle by sending small electrical currents through the body. Cognitive function was assessed using the Japanese version of the Montreal Cognitive Assessment (MoCA-J), with scores below 26 indicating mild cognitive impairment. The study also measured various muscle-related parameters including muscle mass, grip strength, and muscle quality indicators.
Results
Higher phase angles were significantly associated with lower risk of mild cognitive impairment, particularly in women. Women with higher phase angles had 72% lower odds of cognitive problems even after adjusting for age. Phase angle was positively correlated with overall cognitive scores in women and specifically with memory function in both men and women. Other muscle-related measures like mass and strength showed weaker or no significant associations with cognitive function after adjusting for demographic factors.
Limitations
This was a cross-sectional study, so it cannot establish causation between phase angle and cognitive function. The sample included only Japanese adults, limiting generalizability to other populations. The study had a relatively small sample size, particularly for women (100 participants), and included primarily healthy adults seeking routine care rather than those at highest risk for cognitive problems. The researchers also did not measure hormone levels or muscle-derived proteins that might explain the observed relationships.
Funding and Disclosures
The study was supported by multiple Grant-in-Aid awards from the Japan Society for the Promotion of Science, grants from the Smoking Research Foundation, and funding from the Japan Diabetes Society. The authors declared no conflicts of interest. The research was conducted according to ethical guidelines and registered in the University Hospital Medical Information Network system.
Publication Information
This study was published in the Journal of Cachexia, Sarcopenia and Muscle in 2025, Volume 16, article number e13820. The research was conducted by Kentaro Ikeue and colleagues from multiple Japanese institutions including the NHO Kyoto Medical Center and Doshisha University. The paper was received in September 2024, revised in March 2025, and accepted in March 2025.







